Tag: Pharma
CPHI & PMEC India draws 50,000+ global stakeholders to set the...
From 2026 onward, CPHI and PMEC India by Informa Markets in India will transition into two specialised shows: CPHI at Dwarka and PMEC at IEML on consecutive days
IPA’s 10th Advanced GMP Workshop calls for unified quality vision to...
The two-day virtual programme brought together more than 20 industry leaders, domain experts, and international regulators
OPPI Annual Summit 2025 highlights the ‘Power of Partnership’ in driving...
The Summit highlights how collaboration, trust, and digital innovation are shaping India’s evolution into a global pharma powerhouse committed to equitable access and patient-centric care
AstraZeneca and Sun Pharma partner to help patients living with Hyperkalaemia...
This exclusive agreement is aimed at further accelerating availability of SZC, an innovative and highly effective treatment for Hyperkalaemia to more patients across India
Pfizer launches new Rimegepant oral medication in India for rapid migraine...
Rimegepant is an orally disintegrating tablet (ODT) - a class of medications called calcitonin gene-related peptide (CGRP) receptor antagonist
ENTOD Pharmaceuticals and MATANAND Foundation lead India’s largest awareness campaign to...
Over 2,500 ophthalmologists and 5,000 volunteers are expected to participate nationwide
Lupin establishes a new global standard in sustainable pharma with an...
This remarkable increase from 17 in 2021 ranks among the fastest for pharmaceutical companies, establishing Lupin as a leader in sustainable growth
PRASHO and Pfizer collaborate to enhance migraine awareness with corporate workshops...
The workshops, led by neurologists from KIMS and Yashoda Hospitals along with PRASHO’s public-health team, focus on early recognition, treatment, and workplace adaptation strategies
Novo Nordisk India partners with Emcure Pharma to commercialize ‘Poviztra’ in...
Emcure Pharma becomes the first Indian company with exclusive rights to distribute and commercialise Poviztra®, semaglutide injection 2.4 mg, for weight loss in India
Zydus receives USFDA Orphan Drug Designation for Desidustat for the treatment...
Orphan drug designation by the USFDA for Desidustat, provides eligibility for a potential seven-year marketing exclusivity subject to the USFDA approval